PRESS-NEWS.org - Press Release Distribution
FREE PRESS RELEASES DISTRIBUTION

Early antiviral response in the nose may determine the course of COVID-19

Cells sampled at the time of diagnosis from patients who later developed severe COVID-19 show a muted antiviral response, study finds

2021-07-23
(Press-News.org) At a glance:

Researchers studied cells collected by nasal swabs at the moment of diagnosis for both mild and severe COVID-19 patients

Cells taken from patients who went on to develop severe disease had a muted antiviral response compared to those who went on to develop mild disease

This suggests that it may be possible to develop early interventions that prevent severe COVID-19 from developing

The team also identified infected host cells and pathways associated with protection against infection that may enable new therapeutic strategies for COVID-19 and other respiratory viral infections

CAMBRIDGE, MA (July 23, 2021) -- Over the past 18 months, researchers have learned much about COVID-19 and its viral cause, SARS-CoV-2. They know how the virus enters the body, coming in through the nose and mouth and beginning its infection in the mucus layers of the nasal passageway. They know that infections that remain in the upper airway are likely to be mild or asymptomatic, while infections that progress down the airway to the lungs are much more severe and can lead to fatal disease. And they have identified common risk factors for severe disease, like age, gender, and obesity. But there are still many unanswered questions -- such as when, and where, the course of severe COVID-19 is determined. Does the pathway to severe disease begin only after the body has failed to control mild disease, or could it start much earlier than that?

Researchers at the Ragon Institute of MGH, MIT, and Harvard; the Broad Institute of MIT and Harvard; Boston Children's Hospital (BCH); MIT; and the University of Mississippi Medical Center (UMMC) wondered whether this path towards severe disease could start much earlier than expected -- perhaps even within the initial response created when the virus enters the nose.

To test this, they studied cells taken from nasal swabs of patients at the time of their initial COVID-19 diagnosis, comparing patients who went on to develop mild COVID-19 to those who progressed into more severe disease and eventually required respiratory support. Their results showed that patients who went on to develop severe COVID-19 exhibited a much more muted antiviral response in the cells collected from those early swabs, compared to patients who had a mild course of disease. The paper appears in Cell.

"We wanted to understand if there were pronounced differences in samples taken early in the course of disease that were associated with different severities of COVID-19 as the disease progressed," said co-senior author José Ordovás-Montañés, an associate member in the Klarman Cell Observatory at Broad and assistant professor at BCH and Harvard Medical School. "Our findings suggest that the course of severe COVID-19 may be determined by the body's intrinsic antiviral response to initial infection, opening up new avenues for early interventions that could prevent severe disease."

To understand the early response to infection, Sarah Glover of the Division of Digestive Diseases at UMMC and her laboratory collected nasal swabs from 58 people. Thirty-five swabs came from COVID-19 patients, taken at the time of diagnosis, representing a variety of disease states from mild to severe. Seventeen swabs came from healthy volunteers and six came from patients with respiratory failure due to other causes. The team isolated individual cells from each sample and sequenced them, looking for RNA that would indicate what kind of proteins the cells were making -- a proxy for understanding what a given cell is doing at the moment of collection.

Cells use RNA as instructions to make proteins -- tools, machinery, and building blocks used within and by the cell to perform different functions and respond to its environment. By studying the collection of RNA in a cell -- its transcriptome -- researchers understand how a cell is responding, at that particular moment in time, to environmental changes such as a viral infection. Researchers can even use the transcriptome to see if individual cells are infected by an RNA virus like SARS-CoV-2.

Alex Shalek, co-senior author on the study, a member of the Ragon Institute of MGH, MIT, and Harvard, and institute member at Broad, specializes in studying the transcriptomes of individual cells. His lab has helped develop innovative approaches to sequence thousands of single cells from low-input clinical samples, like the nasal swab of COVID-19 patients, and uses the resulting data to create high-resolution pictures of the body's orchestrated response to infection at the sample site.

"Our single-cell sequencing approaches allow us to comprehensively study the body's response to disease at a specific moment in time," said Shalek, who is also an associate professor at MIT in the Institute for Medical Engineering & Science, the Department of Chemistry, and the Koch Institute for Integrative Cancer Research. "This gives us the ability to systematically explore features that differentiate one course of disease from another as well as cells that are infected from those that are not. We can then leverage this information to guide the development of more effective preventions and cures for COVID-19 and other viral infections."

Ordovás-Montañés's lab studies inflammatory responses and their memory, specializing in those found in epithelial cells -- the top layer of cells, like those that line your nasal passageways and are collected by nasal swabs. Working with the Shalek lab and that of Bruce Horwitz, a senior associate physician in the BCH Division of Emergency Medicine, the researchers interrogated how both epithelial and immune cells were responding to early COVID-19 infection from the single-cell transcriptome data.

First, the team found that the antiviral response, driven by a family of proteins called interferons, was much more muted in patients who went on to develop severe COVID-19. Second, patients with severe COVID-19 had higher amounts of highly inflammatory macrophages, immune cells that contribute to high amounts of inflammation, often found in severe or fatal COVID-19.

Since these samples were taken well before COVID-19 had reached its peak state of disease in the patients, both these findings indicate that the course of COVID-19 may be determined by the initial or very early response of the nasal epithelial and immune cells to the virus. The lack of strong initial antiviral response may allow the virus to spread more rapidly, increasing the chances that it can move from the upper to lower airways, while the recruitment of inflammatory immune cells could help drive the dangerous inflammation in severe disease.

Finally, the team also identified infected host cells and pathways associated with protection against infection -- cells and responses unique to patients that went on to develop a mild disease. These findings may allow researchers to discover new therapeutic strategies for COVID-19 and other respiratory viral infections.

If, as the team's evidence suggests, the early stages of infection can determine disease, it opens a path for scientists to develop early interventions that can help prevent severe COVID-19 from developing. The team's work even identified potential markers of severe disease, genes that were expressed in mild COVID-19 but not in severe COVID-19. 

"Nearly all our severe COVID-19 samples lacked expression of several genes we would typically expect to see in an antiviral response," said Carly Ziegler, a graduate student in the Health Science and Technology program at MIT and Harvard and one of the study's co-first authors. "If further studies support our findings, we could use the same nasal swabs we use to diagnose COVID-19 to identity potentially severe cases before severe disease develops, creating an opportunity for effective early intervention."

INFORMATION:

Support for this study was provided by the Chan Zuckerberg Initiative, the Richard and Susan Smith Family Foundation, the AGA Research Foundation, the New York Stem Cell Foundation, the National Institute of Diabetes and Digestive and Kidney Diseases, the National Institute of General Medical Sciences, the National Institute on Aging, the Leona M. and Harry B. Helmsley Charitable Trust, the Crohn's and Colitis Foundation, the Ragon Institute of MGH, MIT and Harvard, and other sources.

About the Ragon Institute of MGH, MIT and Harvard The Ragon Institute of MGH, MIT and Harvard was established in 2009 with a gift from the Phillip T. and Susan M. Ragon Foundation, creating a collaborative scientific mission among these institutions to harness the immune system to combat and cure human diseases. The Ragon Institute draws scientists, clinicians and engineers from diverse backgrounds and areas of expertise to study and understand the immune system with the goal of benefiting patients. For more information, visit http://www.ragoninstitute.org

About Broad Institute of MIT and Harvard The Broad Institute of MIT and Harvard was founded in 2003 to empower this generation of creative scientists to transform medicine with new genome-based knowledge. The Broad Institute seeks to describe the molecular components of life and their connections; discover the molecular basis of major human diseases; develop effective new approaches to diagnostics and therapeutics; and disseminate discoveries, tools, methods and data openly to the entire scientific community.

Founded by MIT, Harvard and its affiliated hospitals, and the visionary Los Angeles philanthropists Eli and Edythe L. Broad, the Broad Institute includes faculty, professional staff and students from throughout the MIT and Harvard biomedical research communities and beyond, with collaborations spanning over a hundred private and public institutions in more than 40 countries worldwide. For further information about the Broad Institute, go to http://www.broadinstitute.org.



ELSE PRESS RELEASES FROM THIS DATE:

Comprehensive clinical sequencing opens door to the promise of precision medicine

Comprehensive clinical sequencing opens door to the promise of precision medicine
2021-07-23
St. Jude Children's Research Hospital investigators have demonstrated that comprehensive genomic sequencing of all pediatric cancer patients is feasible and essential to capitalize on the lifesaving potential of precision medicine. Results from the St. Jude Genomes for Kids study appear online today in the journal Cancer Discovery. Whole genome and whole exome sequencing of germline DNA was offered to all 309 patients who enrolled in the study. Whole genome, whole exome and RNA sequencing of tumor DNA was carried out for the 253 patients for whom adequate tumor samples were available. Overall, 86% of patients had at least one ...

Sharks, lies, and videotape: Scientists document problems with shark week

Sharks, lies, and videotape: Scientists document problems with shark week
2021-07-23
MEADVILLE, PA - July 22, 2021 - Shark Week is many things. First and foremost, it's a week of shark-themed documentary programming on the Discovery Channel. Now in its 33rd year, it's the longest-running cable event in history. It's the biggest audience that marine biologists and ocean conservationists get, attracting millions of viewers who might otherwise not ever think about sharks at all. It's a stage that has launched careers of shark scientists and inspired many others to pursue jobs as ocean scientists. However, a new analysis shows that Shark Week is also deeply flawed in ways that undermine its goals, potentially harming both sharks and shark scientists. To document just how pervasive ...

Making negative opinions agreeable: Study finds social sharing happens in terms of support

Making negative opinions agreeable: Study finds social sharing happens in terms of support
2021-07-23
Toronto -- People post 500 million tweets and 4 billion pieces of content on Facebook a day. What makes them do it? An urge to share and connect with others seems obvious. But, despite how toxic the social media sandbox can get, people more often share attitudes that are framed in terms of support instead of opposition, according to new research. That happens regardless of whether the opinion itself is positive or negative. Take gun control. The research found that people were likelier to express themselves on that issue in terms of, "I support allowing guns," or, "I support banning guns," versus, "I oppose banning guns," or, "I oppose allowing guns." "There are a lot of controversial issues where both sides talk about what they support - pro-life and pro-choice on abortion, for example," ...

Dalian Coherent Light Source reveals strong isotope effects in photodissociation of water isotopolog

Dalian Coherent Light Source reveals strong isotope effects in photodissociation of water isotopolog
2021-07-23
Recently, a research group led by Prof. YUAN Kaijun and Prof. YANG Xueming from the Dalian Institute of Chemical Physics (DICP) of the Chinese Academy of Sciences revealed strong isotope effects in photodissociation of the water isotopologue (HOD) using the Dalian Coherent Light Source. Their findings were published in Science Advances on July 23. "Our experimental results illustrate dramatically different quantum state population distributions of OH and OD fragments from HOD photodissociation. The branching ratios of the H+OD and D+OH channels display large wavelength-dependent isotopic fractionation," said Prof. YUAN. Because ...

New understanding of cell stability with potential to improve immune cell therapies

2021-07-23
Research in mice, published today in Science Immunology by researchers at the Babraham Institute, UK and VIB-KU Leuven, Belgium, provides two solutions with potential to overcome a key clinical limitation of immune cell therapies. Regulatory T cells have potential in treating autoimmunity and inflammatory diseases yet they can switch from a protective to damaging function. By identifying the unstable regulatory T cells, and understanding how they can be purged from a cell population, the authors highlight a path forward for regulatory T cell transfer therapy. Cell therapy is based on purifying cells from a patient, growing them up in cell culture to improve their properties, and then reinfusing them into the patient. Professor Adrian ...

New organ-on-a-chip finds crucial interaction between blood, ovarian cancer tumors

New organ-on-a-chip finds crucial interaction between blood, ovarian cancer tumors
2021-07-23
In the evolving field of cancer biology and treatment, innovations in organ-on-a-chip microdevices allow researchers to discover more about the disease outside the human body. These organs-on-chips serve as a model of the state an actual cancer patient is in, thus allowing an opportunity to finding the correct treatment before administering it to the patient. At Texas A&M University, researchers are pushing these devices to new levels that could change the way clinicians approach cancer treatment, particularly ovarian cancer. The team has recently submitted a patent disclosure with the Texas A&M Engineering Experiment Station. "We claim several novelties in technological ...

Using silicone wristbands to measure air quality

Using silicone wristbands to measure air quality
2021-07-23
A study by researchers at the Texas A&M University School of Public Health shows that inexpensive and convenient devices such as silicone wristbands can be used to yield quantitative air quality data, which is particularly appealing for periods of susceptibility such as pregnancy. The research team found that the wristbands, when used as passive samplers, have the ability to bind smaller molecular weight semi-volatile polycyclic aromatic hydrocarbons (PAHs) -- a class of chemicals that occur naturally in coal, crude oil and gasoline and are produced when coal, oil, gas, wood, garbage and tobacco are burned -- in a similar pattern as active sampling. Published recently in Nature's ...

Neuroscientists posit that brain region is a key locus of learning

Neuroscientists posit that brain region is a key locus of learning
2021-07-23
Small and seemingly specialized, the brain's locus coeruleus (LC) region has been stereotyped for its outsized export of the arousal-stimulating neuromodulator norepinephrine. In a new paper and with a new grant from the National Institutes of Health, an MIT neuroscience lab is making the case that the LC is not just an alarm button but has a more nuanced and multifaceted impact on learning, behavior and mental health than it has been given credit for. With inputs from more than 100 other brain regions and sophisticated control of where and when it sends out norepinephrine (NE), the LC's tiny population of surprisingly diverse cells may represent an important regulator of learning from ...

High school student presents on oral-health impact profile 5: analyzing a private practice adult population's distribution

2021-07-23
Alexandria, Va., USA - Hiba Nasir, Wayzata High School, Plymouth, Minn., presented the poster "Oral-Health Impact Profile 5: Analyzing A Private Practice Adult Population's Distribution" at the virtual 99th General Session & Exhibition of the International Association for Dental Research (IADR), held in conjunction with the 50th Annual Meeting of the American Association for Dental Research (AADR) and the 45th Annual Meeting of the Canadian Association for Dental Research (CADR), on July 21-24, 2021. Nasir, a high school student, along with Sheila Riggs, University of Minnesota, Minneapolis, USA, performed an observational study to understand the ...

Strategies for disseminating guidance to dentists during the COVID-19 pandemic

2021-07-23
Alexandria, Va., USA - Ruth Lipman, American Dental Association (ADA) Science and Research Institute, Chicago, Ill., U.S., presented the poster "Strategies for Disseminating Guidance to Dentists during the COVID-19 Pandemic" at the virtual 99th General Session & Exhibition of the International Association for Dental Research (IADR), held in conjunction with the 50th Annual Meeting of the American Association for Dental Research (AADR) and the 45th Annual Meeting of the Canadian Association for Dental Research (CADR), on July 21-24, 2021. Rapidly formulated, actionable infection risk mitigation strategies for dental care professionals were needed during the initial acceleration phase of the COVID-19 ...

LAST 30 PRESS RELEASES:

Scientists model 'true prevalence' of COVID-19 throughout pandemic

New breakthrough to help immune systems in the fight against cancer

Through the thin-film glass, researchers spot a new liquid phase

Administering opioids to pregnant mice alters behavior and gene expression in offspring

Brain's 'memory center' needed to recognize image sequences but not single sights

Safety of second dose of mRNA COVID-19 vaccines after first-dose allergic reactions

Changes in disparities in access to care, health after Medicare eligibility

Use of high-risk medications among lonely older adults

65+ and lonely? Don't talk to your doctor about another prescription

Exosome formulation developed to deliver antibodies for choroidal neovascularization therapy

Second COVID-19 mRNA vaccine dose found safe following allergic reactions to first dose

Plant root-associated bacteria preferentially colonize their native host-plant roots

Rare inherited variants in previously unsuspected genes may confer significant risk for autism

International experts call for a unified public health response to NAFLD and NASH epidemic

International collaboration of scientists rewrite the rulebook of flowering plant genetics

Improving air quality reduces dementia risk, multiple studies suggest

Misplaced trust: When trust in science fosters pseudoscience

Two types of blood pressure meds prevent heart events equally, but side effects differ

New statement provides path to include ethnicity, ancestry, race in genomic research

Among effective antihypertensive drugs, less popular choice is slightly safer

Juicy past of favorite Okinawan fruit revealed

Anticipate a resurgence of respiratory viruses in young children

Anxiety, depression, burnout rising as college students prepare to return to campus

Goal-setting and positive parent-child relationships reduce risk of youth vaping

New research identifies cancer types with little survival improvements in adolescents and young adul

Oncotarget: Replication-stress sensitivity in breast cancer cells

Oncotarget: TERT and its binding protein: overexpression of GABPA/B in gliomas

Development of a novel technology to check body temperature with smartphone camera

The mechanics of puncture finally explained

Extreme heat, dry summers main cause of tree death in Colorado's subalpine forests

[Press-News.org] Early antiviral response in the nose may determine the course of COVID-19
Cells sampled at the time of diagnosis from patients who later developed severe COVID-19 show a muted antiviral response, study finds